Literature DB >> 1331728

Oral contraceptive use and human papillomavirus infection in women without abnormal cytological results.

G Veress1, T Csiky-Mészáros, J Czeglédy, L Gergely.   

Abstract

Both experimental and epidemiological data support the idea that oral contraceptive (OC) use may have a stimulating effect to a certain point on cervical carcinogenesis. The current investigation tries to answer the question whether OC use might have an influence on early human papillomavirus (HPV) infections. A total of 425 women without abnormal cytological results were examined colposcopically, and filter in situ hybridisation (FISH) was used to determine the presence of human papillomavirus (HPV) types 6, 11, 16 and 18. Eighty-one cervical specimens (19.1%) were found to be positive for one or more of the HPV types in FISH. HPV positivity was found to correlate with age and parity, being the highest among women under 25 and with less than two births. The use of OCs was inversely correlated with the presence of ectopy or dysplasia in this group of women. On the other hand, HPV positivity was not significantly higher among OC users than among non-users in any colposcopic group. Neither the type of pill used, nor the duration of use had any significant effect on HPV positivity. Further investigations are needed to evaluate the effects of OC use on more severe HPV-induced cervical lesions.

Entities:  

Keywords:  Contraception; Contraceptive Methods; Developed Countries; Diseases; Eastern Europe; Europe; Family Planning; Hpv; Hungary; Oral Contraceptives; Research Report; Viral Diseases

Mesh:

Substances:

Year:  1992        PMID: 1331728     DOI: 10.1007/bf00215764

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  16 in total

1.  Statistical aspects of the analysis of data from retrospective studies of disease.

Authors:  N MANTEL; W HAENSZEL
Journal:  J Natl Cancer Inst       Date:  1959-04       Impact factor: 13.506

Review 2.  Heterogeneity of the human papillomavirus group.

Authors:  E M de Villiers
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

3.  The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes.

Authors:  K Münger; W C Phelps; V Bubb; P M Howley; R Schlegel
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

4.  Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma.

Authors:  C D Woodworth; J Doniger; J A DiPaolo
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

5.  Human papillomavirus infection of the uterine cervix of women without cytological signs of neoplasia.

Authors:  P G Toon; J R Arrand; L P Wilson; D S Sharp
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-15

6.  Prevalence of genital papillomavirus infection among women attending a college student health clinic or a sexually transmitted disease clinic.

Authors:  N B Kiviat; L A Koutsky; J A Paavonen; D A Galloway; C W Critchlow; A M Beckmann; J K McDougall; M L Peterson; C E Stevens; C M Lipinski
Journal:  J Infect Dis       Date:  1989-02       Impact factor: 5.226

Review 7.  Human papillomaviruses: are we ready to type?

Authors:  A Roman; K H Fife
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

8.  Oral contraceptive use, human papillomavirus infection, and risk of early cytological abnormalities of the cervix.

Authors:  B P Negrini; M H Schiffman; R J Kurman; W Barnes; L Lannom; K Malley; L A Brinton; G Delgado; S Jones; J G Tchabo
Journal:  Cancer Res       Date:  1990-08-01       Impact factor: 12.701

9.  Detection of human papillomavirus deoxyribonucleic acid by filter in situ hybridization during pregnancy.

Authors:  J Czeglédy; L Gergely; I Endrödi
Journal:  J Med Virol       Date:  1989-08       Impact factor: 2.327

10.  The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones.

Authors:  B Gloss; H U Bernard; K Seedorf; G Klock
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

View more
  1 in total

1.  Combined oral contraceptive use increases HPV persistence but not new HPV detection in a cohort of women from Thailand.

Authors:  Morgan Marks; Patti E Gravitt; Swati B Gupta; Kai-Li Liaw; Amha Tadesse; Esther Kim; Chailert Phongnarisorn; Virach Wootipoom; Pissimai Yuenyao; Charoen Vipupinyo; Somchai Sriplienchan; David D Celentano
Journal:  J Infect Dis       Date:  2011-09-29       Impact factor: 5.226

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.